Suppr超能文献

透明质酸钠-硫酸软骨素与皮质类固醇治疗肱骨外上髁炎的疗效比较:一项前瞻性随机试验

Comparison of the effects of sodium hyaluronate-chondroitin sulphate and corticosteroid in the treatment of lateral epicondylitis: a prospective randomized trial.

作者信息

Tosun Haci Bayram, Gumustas Seyitali, Agir Ismail, Uludag Abuzer, Serbest Sancar, Pepele Demet, Ertem Kadir

机构信息

Department of Orthopaedics and Traumatology, Faculty of Medicine, Adiyaman University, 02100, Adiyaman, Turkey.

Department of Orthopaedics and Traumatology, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey.

出版信息

J Orthop Sci. 2015 Sep;20(5):837-43. doi: 10.1007/s00776-015-0747-z. Epub 2015 Jul 3.

Abstract

BACKGROUND

Hyaluronic acid and glycosaminoglycans have shown positive effects in improving lateral epicondylitis and other tendinosis conditions. Therefore, we designed a prospective, randomized study to compare the effects of a combined sodium hyaluronate and chondroitin sulfate (HA + CS) injection versus a triamcinolone injection in the treatment of lateral epicondylitis.

METHODS

In total, 57 consecutive patients with clinically diagnosed lateral epicondylitis were divided randomly into two groups. In the HA + CS group, 25 patients received a single injection of a solution containing an HA + CS combination and prilocaine HCl, while the 32 patients in the triamcinolone group received a single injection of a solution of triamcinolone and prilocaine HCl. We evaluated the pain and function outcome measures using the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire at the beginning of the study, and 3 and 6 months after the injection. Additionally, the Minimum Clinically Important Difference values and percentage changes in the PRTEE subscale scores between the assessments were calculated.

RESULTS

No serious adverse events were reported throughout the study. The mean pain and function scores for the HA + CS and triamcinolone groups had significantly improved at 3 months, but the mean function scores in the HA + CS group were statistically significantly better when compared to the triamcinolone group. At 6 months, both groups had significantly improved mean pain and function scores, compared to the baseline scores; however, the mean pain and function scores in the 6-month HA + CS treatment group were better than in the 6-month triamcinolone group. The relative change for the mean total score in the HA + CS group was much better when compared with the triamcinolone group, and the HA + CS treatment group showed clinically significant improvement when compared with triamcinolone group at 3 and 6 months.

CONCLUSIONS

This study supports the idea that for a single injection treatment of patients with lateral epicondylitis, a combination injection of HA + CS may offer better pain benefits for 6 months after injection, when compared to triamcinolone.

TYPE OF STUDY/LEVEL OF EVIDENCE: Level II, Randomized Clinical Trial, Prospective Comparative Study.

摘要

背景

透明质酸和糖胺聚糖已显示出对改善外侧上髁炎和其他肌腱病状况有积极作用。因此,我们设计了一项前瞻性随机研究,以比较透明质酸钠和硫酸软骨素联合注射(HA + CS)与曲安奈德注射治疗外侧上髁炎的效果。

方法

总共57例临床诊断为外侧上髁炎的连续患者被随机分为两组。在HA + CS组中,25例患者接受了一次含有HA + CS组合和盐酸丙胺卡因的溶液注射,而曲安奈德组的32例患者接受了一次曲安奈德和盐酸丙胺卡因溶液注射。我们在研究开始时以及注射后3个月和6个月,使用患者自评网球肘评估(PRTEE)问卷评估疼痛和功能结局指标。此外,还计算了评估之间PRTEE子量表得分的最小临床重要差异值和百分比变化。

结果

在整个研究过程中未报告严重不良事件。HA + CS组和曲安奈德组的平均疼痛和功能评分在3个月时均有显著改善,但与曲安奈德组相比,HA + CS组的平均功能评分在统计学上显著更好。在6个月时,与基线评分相比,两组的平均疼痛和功能评分均有显著改善;然而,6个月HA + CS治疗组的平均疼痛和功能评分优于6个月曲安奈德组。与曲安奈德组相比,HA + CS组的平均总分相对变化要好得多,并且在3个月和6个月时,HA + CS治疗组与曲安奈德组相比显示出临床显著改善。

结论

本研究支持这样的观点,即对于外侧上髁炎患者的单次注射治疗,与曲安奈德相比,HA + CS联合注射在注射后6个月可能提供更好的疼痛缓解效果。

研究类型/证据水平:II级,随机临床试验,前瞻性比较研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验